Company registration number 13693640 (England and Wales)
Ataraxia 12 Limited
Unaudited financial statements
For the year ended 31 December 2024
Ataraxia 12 Limited
Contents
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 6
Ataraxia 12 Limited
Statement of financial position
As at 31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
3
6,612,977
2,675,435
Current assets
Debtors
4
868,850
164,689
Cash at bank and in hand
8,986
4,072
877,836
168,761
Creditors: amounts falling due within one year
5
(866,727)
(1,355,235)
Net current assets/(liabilities)
11,109
(1,186,474)
Total assets less current liabilities
6,624,086
1,488,961
Creditors: amounts falling due after more than one year
6
(6,718,316)
(1,540,611)
Net liabilities
(94,230)
(51,650)
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
(95,230)
(52,650)
Total equity
(94,230)
(51,650)
Ataraxia 12 Limited
Statement of financial position (continued)
As at 31 December 2024
- 2 -

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 7 August 2025 and are signed on its behalf by:
Mr C Parker
Director
Company registration number 13693640 (England and Wales)
Ataraxia 12 Limited
Notes to the financial statements
For the year ended 31 December 2024
- 3 -
1
Accounting policies
Company information

Ataraxia 12 Limited is a private company limited by shares incorporated in England and Wales. The registered office is Venture House, St. Leonards Road, Allington, Maidstone, England, ME16 0LS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company is reliant on ongoing support from the directors and the directors are committed to this ongoing support. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Ataraxia 12 Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and amounts due from group companies and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, other loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Ataraxia 12 Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
0
3
3
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
6,612,977
2,675,435
Movements in fixed asset investments
Shares in associates
£
Cost or valuation
At 1 January 2024
2,675,435
Additions
3,937,542
At 31 December 2024
6,612,977
Carrying amount
At 31 December 2024
6,612,977
At 31 December 2023
2,675,435
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
12,639
12,918
Amounts owed by group undertakings
688,364
-
0
Other debtors
167,847
151,771
868,850
164,689
Ataraxia 12 Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
- 6 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
-
0
1,950
Taxation and social security
11,471
6,977
Other creditors
855,256
1,346,308
866,727
1,355,235
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
6,718,316
1,540,611
2024-12-31 2024-01-01 false false false 07 August 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr David Alexander Lewis Clapp Mr P G Cullum Mr Christian Parker 13693640 2024-01-01 2024-12-31 13693640 2024-12-31 13693640 2023-12-31 13693640 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 13693640 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 13693640 core:ShareCapital 2024-12-31 13693640 core:ShareCapital 2023-12-31 13693640 core:RetainedEarningsAccumulatedLosses 2024-12-31 13693640 core:RetainedEarningsAccumulatedLosses 2023-12-31 13693640 bus:Director3 2024-01-01 2024-12-31 13693640 2023-01-01 2023-12-31 13693640 core:CurrentFinancialInstruments 2024-12-31 13693640 core:CurrentFinancialInstruments 2023-12-31 13693640 core:WithinOneYear 2024-12-31 13693640 core:WithinOneYear 2023-12-31 13693640 core:Non-currentFinancialInstruments 2024-12-31 13693640 core:Non-currentFinancialInstruments 2023-12-31 13693640 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13693640 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 13693640 bus:FRS102 2024-01-01 2024-12-31 13693640 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 13693640 bus:Director1 2024-01-01 2024-12-31 13693640 bus:Director2 2024-01-01 2024-12-31 13693640 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP